metabolic pipeline - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of commercial shipping and naval activity in the Strait of Hormuz, as Iran reopens the key oil transit route while uncertainty over the United States naval blockade continues.

Strait of Hormuz reopens on paper, yet ships turn back as Iran and US clash over blockade terms

TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record

Representative image of a large-scale copper mining operation in Chile, reflecting investor focus on Antofagasta PLC shares, Q1 2026 production stability, and the Centinela Second Concentrator growth story.

Antofagasta (LSE: ANTO) surges 5% as Q1 output beats consensus and Centinela build holds schedule

Shubman Gill’s 86 steers Gujarat Titans past Kolkata Knight Riders in IPL 2026

Representative image of Eli Lilly and Company’s evolving drug portfolio beyond Zepbound, featuring pills and injectables that highlight its shift toward oral GLP-1 therapies and next-generation metabolic treatments.

Read More

Pharma Industry News

What’s next after Zepbound? Inside Eli Lilly and Company’s pipeline beyond GLP-1

Discover which drugs Eli Lilly and Company is betting on after Zepbound, including oral GLP-1 pills and next-generation incretins that could redefine the global obesity treatment market.

December 8, 2025

web analytics